AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 148 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,940,447 | -42.5% | 6,416,998 | 0.0% | 0.81% | -40.0% |
| Q2 2023 | $71,164,508 | -27.8% | 6,416,998 | 0.0% | 1.34% | -39.7% |
| Q1 2023 | $98,500,919 | -18.6% | 6,416,998 | +17.6% | 2.23% | -9.2% |
| Q4 2022 | $121,036,087 | +242.0% | 5,454,533 | +151.7% | 2.46% | +225.2% |
| Q3 2022 | $35,393,000 | +12.4% | 2,167,391 | 0.0% | 0.76% | -10.1% |
| Q2 2022 | $31,492,000 | -21.3% | 2,167,391 | 0.0% | 0.84% | -3.8% |
| Q1 2022 | $40,032,000 | +297.6% | 2,167,391 | +411.6% | 0.87% | +390.4% |
| Q4 2021 | $10,069,000 | -3.5% | 423,616 | 0.0% | 0.18% | +22.8% |
| Q3 2021 | $10,434,000 | – | 423,616 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |